Following Recent FDA Clearance for Cholecystectomy, the Company is now 510(k) pending for Gynecology. This Submission Builds On Extensive Global Clinical Experience in Gynecology and Continues CMR’s U.S. Market Expansion.
Following Recent FDA Clearance for Cholecystectomy, the Company is now 510(k) pending for Gynecology. This Submission Builds On Extensive Global Clinical Experience in Gynecology and Continues CMR’s U.S. Market Expansion.
CMR Surgical today announced that more than 45,000 patients worldwide have now been treated using the Versius® Surgical Robotic System, marking a major milestone for the Cambridge, U.K.-based surgical robotics company as it prepares to expand into the United States.
CMR Surgical, a global medical technology company, today announces its second-generation surgical robotic platform, Versius Plus, has received 510(k) clearance from the United States Food and Drug Administration (FDA) for cholecystectomy procedures.
View all press releases ~ CMR Surgical has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital~ The latest funding will fuel the global commercialisation of its Versius Surgical Robotic System, particularly in the U.S. market, and support continued investment in surgical robotics innovation~ Versius is … Read more
View all press releases ~ Massimiliano Colella appointed CEO at CMR Surgical, leading the company in its mission to bring the benefits of robotic-assisted minimal access surgery to patients around the world with Versius Press Office +44 (0)1223 755801 [email protected] View Press Kit CMR Surgical (CMR or ‘the Company’), the global surgical robotics business, today … Read more
The U.S. Food and Drug Administration (FDA) has granted CMR Surgical marketing authorization for the Versius Surgical System (Versius) in cholecystectomy, paving the way for the next-generation versatile, adaptable, and digitally driven surgical robot to be introduced in the United States.
CMR Surgical has appointed Markus Bauman as Chief Legal & Business Affairs Officer and will join CMR’s executive leadership team. Michelle Paknad has been appointed as Senior Vice President, Global Business Development.
CMR Surgical appoint Daniel (Dan) Moore, a medical technology veteran, as as Non-Executive Chairman.
